Content Library

Evaluating the safety of a self-amplifying mRNA vaccine in rats

What is self-amplifying mRNA technology? Self-amplifying mRNA (SAM) technology is a relatively novel approach in vaccinology. It consists of an engineered replication-deficient alphavirus genome encoding an RNA-dependent RNA polymerase and the gene of the target antigen. The benefit that SAM technology holds over conventional vaccinology is its potential for the rapid development and large-scale production of a vaccine in the event of an unpredictable epidemic outbreak.

Upcoming Events

Ocular Toxicity Webinar

Date: Thursday March 30 at 10amEST
Learn about Technical Considerations and Pathology Reporting Expectations in this webinar.

ARVO

Date: April 23-27
Location: New Orleans, LA
Stop by our booth #1047

Learn more about StageBio’s COVID-19 response